0.9399
price down icon0.50%   -0.00475
 
loading

Allarity Therapeutics Inc Aktie (ALLR) Neueste Nachrichten

pulisher
Aug 18, 2025

How to forecast Allarity Therapeutics Inc. trends using time seriesTrade Volume Report & Weekly Return Optimization Alerts - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Allarity Therapeutics Delays 10-Q Filing - MSN

Aug 18, 2025
pulisher
Aug 18, 2025

Stock Market Today: Nasdaq 100 Futures Slip— Palo Alto, XP, Allarity Earnings In Focus (UPDATED) - Benzinga

Aug 18, 2025
pulisher
Aug 18, 2025

What machine learning models say about Allarity Therapeutics Inc.Earnings Risk Report & Verified Swing Trading Watchlists - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Palo Alto Networks, Fabrinet And 3 Stocks To Watch Heading Into Monday - Benzinga

Aug 18, 2025
pulisher
Aug 18, 2025

Published on: 2025-08-18 10:13:44 - beatles.ru

Aug 18, 2025
pulisher
Aug 18, 2025

Volatility clustering patterns for Allarity Therapeutics Inc.July 2025 Update & Safe Capital Allocation Plans - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Why Allarity Therapeutics Inc. stock attracts strong analyst attentionPortfolio Risk Summary & Reliable Price Action Trade Plans - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

How to use Fibonacci retracement on Allarity Therapeutics Inc.July 2025 PostEarnings & Free Real-Time Volume Trigger Notifications - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is Allarity Therapeutics Inc. forming a reversal patternWeekly Loss Report & Fast Exit and Entry Trade Guides - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Momentum divergence signals in Allarity Therapeutics Inc. chart2025 Support & Resistance & Fast Gaining Stock Reports - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Allarity Therapeutics Inc. stock volume spike explainedEarnings Growth Report & Free Community Consensus Stock Picks - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Top chart patterns to watch in Allarity Therapeutics Inc.Weekly Trade Review & Capital Efficient Trading Techniques - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Statistical indicators supporting Allarity Therapeutics Inc.’s strengthJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Advanced analytics toolkit walkthrough for Allarity Therapeutics Inc.Quarterly Market Summary & Reliable Breakout Forecasts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Will Allarity Therapeutics Inc. stock benefit from interest rate changesCPI Data & Stock Portfolio Risk Management - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

What makes Allarity Therapeutics Inc. stock price move sharplyInflation Watch & Accurate Entry and Exit Point Alerts - kangso.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Chart based analysis of Allarity Therapeutics Inc. trends2025 Bull vs Bear & Daily Growth Stock Investment Tips - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Allarity Therapeutics Provides Second Quarter 2025 Update, - GlobeNewswire

Aug 16, 2025
pulisher
Aug 16, 2025

Order flow analysis tools used on Allarity Therapeutics Inc.2025 Trading Recap & Technical Entry and Exit Alerts - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Allarity Therapeutics Delays Q2 Earnings Report Due to Audit Review - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

How Allarity Therapeutics Inc. stock performs during market volatilityEarnings Growth Report & Precise Swing Trade Entry Alerts - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Short interest data insights for Allarity Therapeutics Inc.Quarterly Profit Review & Low Risk High Win Rate Stock Picks - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Momentum Indicator Shows Bearish Divergence in Allarity Therapeutics Inc.Bear Alert & Stepwise Trade Signal Implementation - beatles.ru

Aug 15, 2025
pulisher
Aug 15, 2025

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP - Bluefield Daily Telegraph

Aug 15, 2025
pulisher
Aug 15, 2025

Allarity Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 15, 2025
pulisher
Aug 15, 2025

First Patients Dosed: Allarity's Dual-Action Cancer Drug Stenoparib Enters Critical Phase 2 Trial - Stock Titan

Aug 15, 2025
pulisher
Aug 15, 2025

Price action breakdown for Allarity Therapeutics Inc.Weekly Trend Recap & Low Risk Profit Maximizing Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships - Business Upturn

Aug 15, 2025
pulisher
Aug 15, 2025

Will Allarity Therapeutics Inc. bounce back from current support2025 Historical Comparison & Entry Point Strategy Guides - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Chart overlay techniques for tracking Allarity Therapeutics Inc.New Guidance & Safe Entry Momentum Tips - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Identifying reversal signals in Allarity Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Allarity Therapeutics Inc. Included in Top Momentum ScanWeekly Trading Summary & Reliable Price Breakout Signals - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Earnings visualization tools for Allarity Therapeutics Inc.Weekly Trade Analysis & Consistent Income Trade Ideas - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Is Allarity Therapeutics Inc. the Top Chart Pick This WeekJuly 2025 Chart Watch & Target Return Focused Stock Picks - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Analyzing Allarity Therapeutics Inc. with multi timeframe chartsPortfolio Profit Report & Stock Market Timing Techniques - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Identifying reversal signals in Allarity Therapeutics Inc. [July 2025 Intraday Action]AI Powered Market Entry Ideas - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

What MACD signals say about Allarity Therapeutics Inc.Free Early Entry Picks Before News Breakout - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Strategies to average down on Allarity Therapeutics Inc.Weekly Chart Watchlist with Trade Guidance - Newser

Aug 12, 2025
$24.41
price down icon 1.03%
$84.75
price down icon 0.24%
$26.13
price down icon 0.46%
$106.32
price down icon 4.11%
$129.84
price down icon 1.62%
biotechnology ONC
$311.30
price down icon 0.61%
Kapitalisierung:     |  Volumen (24h):